1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-132934 Ac32Az19

BCRP

2021-12 Ac32Az19
HY-132932 Cavα2δ-IN-1

Others

2021-12 Cavα2δ-IN-1
HY-141838 LpxA-IN-1

Others

2021-12 LpxA-IN-1
HY-110033 SCH 39166 hydrobromide

Dopamine Receptor; 5-HT Receptor; Adrenergic Receptor

Metabolic Disease;

Neurological Disease

2021-12 SCH 39166 hydrobromide
HY-76570A (Rac)-5-Hydroxymethyl Tolterodine hydrochloride

mAChR

Neurological Disease

2021-12 (Rac)-5-Hydroxymethyl Tolterodine hydrochloride
HY-141840 GLP-1R modulator C5

Glucagon Receptor

2021-12 GLP-1R modulator C5
HY-N10064 Ficusonolide

Others

2021-12 Ficusonolide
HY-12973 ALK-IN-13

ALK

Cancer

2021-12 ALK-IN-13
HY-109897 CV-6209

Others

Cardiovascular Disease

2021-12 CV-6209
HY-120903 DBCO-C3-Acid

ADC Linker

Cancer

2021-12 DBCO-C3-Acid
HY-141842 GLP-1R modulator L7-028

Glucagon Receptor

2021-12 GLP-1R modulator L7-028
HY-103364 C-021

CCR

Inflammation/Immunology

2021-12 C-021
HY-141834 Carboxylesterase-IN-1

Others

2021-12 Carboxylesterase-IN-1
HY-141839 GLP-1R modulator C16

Glucagon Receptor

2021-12 GLP-1R modulator C16
HY-132937 PRMT5-IN-9

Histone Methyltransferase

2021-12 PRMT5-IN-9
HY-76570 (Rac)-5-Hydroxymethyl Tolterodine

mAChR

Neurological Disease

2021-12 (Rac)-5-Hydroxymethyl Tolterodine
HY-108552 MG-115

Proteasome; Apoptosis

Cancer

2021-12 MG-115
HY-141866 Acid Ceramidase-IN-1

Others

Neurological Disease

2021-11 Acid Ceramidase-IN-1
HY-139707 Thalidomide-NH-CBP/p300 ligand 2

PROTACs; Epigenetic Reader Domain

Cancer

2021-11 Thalidomide-NH-CBP/p300 ligand 2
HY-139607 SSAO inhibitor-1

Monoamine Oxidase

Inflammation/Immunology

2021-11 SSAO inhibitor-1